HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis.

Abstract
A means for determining immune status against shigellosis would significantly improve the design and evaluation of interventional and other epidemiologic studies. Previous case-control studies have indicated the potential role of humoral antilipopolysaccharide antibodies. To test this proposition, 190 soldiers serving in a field unit were monitored prospectively for 2.5 months for shigellosis. Blood samples were taken at the beginning of the follow-up period and tested for serological evidence of prior exposure to Shigella sonnei and Shigella flexneri. The risk for acquiring S. sonnei shigellosis was 3.7 times higher for individuals lacking homologous antibodies (P less than 0.02). The risk for acquiring S. flexneri shigellosis was 2.4 times higher for individuals lacking antibodies, although a low attack rate for S. flexneri resulted in numbers too small to achieve statistical significance. While the importance of the serum antilipopolysaccharide antibodies in protection against the disease remains unclear, these findings demonstrate that they are strong markers of acquired immunity. Serological markers should be incorporated in epidemiologic studies of shigellosis and in the design and evaluation of future trials of potential anti-Shigella vaccines.
AuthorsD Cohen, M S Green, C Block, R Slepon, I Ofek
JournalJournal of clinical microbiology (J Clin Microbiol) Vol. 29 Issue 2 Pg. 386-9 (Feb 1991) ISSN: 0095-1137 [Print] United States
PMID1706731 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Lipopolysaccharides
  • O Antigens
Topics
  • Antibodies, Bacterial (blood)
  • Antigens, Bacterial (immunology)
  • Case-Control Studies
  • Dysentery, Bacillary (epidemiology, immunology)
  • Humans
  • Israel (epidemiology)
  • Lipopolysaccharides (immunology)
  • O Antigens
  • Prospective Studies
  • Shigella (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: